Introduction
Transoral robotic surgery (TORS) was pioneered in 2005 and is now well established in the treatment paradigm of oropharyngeal pathology.1 2 TORS offers a minimally invasive approach to the oropharynx without the morbidity associated with traditional jaw spitting or maxillary swing open techniques. Robotic-assisted surgery also offers the advantages of high-definition three-dimensional vision, tremor filtration, motion scaling, dextrous instrumentation and en bloc tumour resection that is not offered with other minimally invasive techniques.1 3
TORS was first developed for the management of early oropharyngeal malignancy but is expanding beyond this anatomical subsite and has expanding applications, both malignant and benign.4–7 The clear advantages that robotic-assisted surgery provides are likely to continue to evolve and robotic-assisted surgery within the head and neck will continue to expand.
The current remit of TORS is largely limited by transoral access. The upper aerodigestive tract broadly resembles a funnel with the oral aperture the opening and the subglottis the apex. As instruments pass distally down this funnel, the working space and surgical access become more limited. Current robotic systems perform well within the upper portion of this funnel, the oropharynx; however, effective surgery becomes more difficult as the anatomical space narrows. This phenomenon has been coined the ‘funnel effect’ and remains a significant hurdle in the expansion of transoral surgery.8
The robotic surgical landscape is rapidly expanding. Rapid technological development has resulted in the development of multiple novel devices and a rapid market expansion. These novel systems offer single port, flexible and modular devices.9–11 The advent of new technology and surgical systems raises the possibility of overcoming the ‘funnel effect’and expanding TORS into the larynx and other previously limited subsites.12
The Versius Surgical System is a novel robotic platform by CMR Surgical (Cambridge, UK) designed to overcome some of the challenges and limitations associated with currently available robotic systems. The system uses a novel modular design with multijointed instrument arms and a visualisation arm mounted on individual bedside units (BSU). The system can be setup in multiple configurations tailored to the required task. Each BSU is individually portable and can be transported between theatres and hospital sites. The operating surgeon interacts with the system through an open console, which uses polarised glasses to provide three dimensional high-definition optics. The system is operated through hand controls and the console is adjustable allowing the console surgeon to sit or stand.13
The Versius Surgical System has undergone in-human clinical trials for robotic-assisted surgery in gynaecology, general surgery and urology.13–17 The system has proved to be safe and effective in these applications and is in clinical use in general surgery, urology, gynaecology and thoracic surgery. Initial feasibility of the Versius Surgical System for use in TORS and also robotic access to the nasopharynx and anterior skull base via a combined transorbital and transnasal approach has been previously reported by our group.5 18
The initial feasibility work conducted a three cadaver evaluation using two expert TORS surgeons.18 This study aims to build on initial feasibility work and conduct a preclinical evaluation that evaluates and optimises the Versius surgical system for clinical study in TORS. This is in accordance with the IDEAL-D framework and recommendations for surgical innovation and constitutes an IDEAL-D Stage 0 study.19 20